Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable”

[Fill out the form below to register]

Abstract: The Global Clinical Research Organization (CRO) market is expected to grow to $71.7 billion in 2024. Within that growth, Functional Service Provider (FSP) relationships are expected to grow at a CAGR of 5%-6%. Sponsor organizations turn to the FSP model as an outsourcing strategy for multiple reasons. Efficiency, consistency, scalability, global reach, and cost reduction generally top that list. CROs, in turn, have evolved their culture, resourcing, and infrastructure to best suit FSP relationships

Given the increasing reliance on global support models, virtual work teams, and the complexity and increasing amounts of data and advancements in technology – sponsor organizations need more from their FSP partners.   The best-fit partners bring the functional line expertise plus an innovation mindset and tangible methods to identify, and where requested, help organizations to transform their way of operating.

Attendees will learn:

  • How FSP partners can go beyond “Global and Scalable”
  • How to bridge time zones and distance without compromising performance
  • How to create and maintain a culture of alignment with customer goals, standards, and results
  • Innovative methods for leading the charge to bring innovation and efficiencies
  • Sample innovations that have transformed FSP partnership operating models

This webinar is intended for small to mid-size organizations – those utilizing the FSP model today and those considering implementing FSP relationships in the future.

Presenters:

Donnelle LaDouceur, Director, Functional Service Solutions

Jim Balcom, Director, Innovation and Automation

Diederik Van Niekerk, Senior Manager, South Africa Operations

mms holdings fsp functional service provider provision webinar expert solutions services cro pharmaceutical biotech medical device industry biostatistics programming data science medical writing drug safety pharmacovigilance

Register for the webinar

Suggested For You

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer

perspectives

August 13th, 2024

How To Navigate The Nonclinical Evaluation Landscape Of Biopharmaceuticals

perspectives

August 5th, 2024

Ensuring Robust Data Privacy and Protection: An Overview of the MMS Framework

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma